ArticleCureus2025
A Comparative Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) and Conventional Methods for the Diagnosis of Dermatophytes.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Consensus-based Guideline on tinea capitis.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026Guideline
- Evaluation of MALDI-TOF MS for identification of clinical filamentous fungi in a routine mycology laboratory.BMC microbiology · 2026Article
- Conventional Diagnostic Approaches to Dermatophytosis: Insights from a Three-Year Survey at a Public Dermatology Institute in Italy (2019-2021).Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Dermatophytosis refers to superficial skin fungal infection in humans. The laboratory diagnosis of the pathogens causing dermatophytosis is challenging. In recent years, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as an effective tool for diagnosing and identifying microorganisms. This study aimed to compare MALDI-TOF MS with conventional methods of identification to assess the existing knowledge on the diagnostic capabilities of MALDI-TOF MS for dermatophyte infections. The findings of this study have significant implications for clinical practice, public health, and future research endeavors in dermatophytosis diagnostics. Methods This prospective study was conducted in the Post Graduate Department of Microbiology at a tertiary-level teaching Medical University over 12 months, from January 1, 2020, to December 31, 2020. A total of 138 clinical cases among the patients attending the skin OPD with clinical features suggesting fungal skin infections were included. Conventional methods such as microscopy, slide culture, biochemical tests, and culture on Sabouraud dextrose agar (SDA) were used as the reference standard for species identification. ATCC (American Type Culture Collection) strains of dermatophytes were used for quality control. The MALDI-TOF Vitek MS (BioMerieux, Craponne, France) system was employed for comparison, and the agreement between the two methods was determined. Results Of the 138 samples, 89 were from males and 49 from females. The majority were taken from the skin (103, 75%) samples followed by nails (30, 21%) and hair (5, 4%). Tinea corporis was the most common clinical type, seen in 81 cases (58.70%), followed by onychomycosis seen in 30 (21.74%) cases, and tinea cruris seen in 16 (11.59%) cases. The most prevalent isolate discovered in tinea corporis was
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.